BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Progensa PCA3 assay regulatory update

FDA accepted for review a PMA from Gen-Probe for the Progensa PCA3 assay to aid in determining the need for a repeat biopsy in men suspected of having prostate cancer. According to the company,...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >